2.75 USD
+0.17
6.59%
At close Nov 8, 4:00 PM EST
After hours
2.68
-0.07
2.55%
1 day
6.59%
5 days
-13.25%
1 month
5.77%
3 months
1.10%
6 months
14.58%
Year to date
-4.51%
1 year
-10.13%
5 years
-99.26%
 

About: Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Employees: 5

0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

1.12% less ownership

Funds ownership: 6.76% [Q1] → 5.64% (-1.12%) [Q2]

21% less funds holding

Funds holding: 19 [Q1] → 15 (-4) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

54% less capital invested

Capital invested by funds: $341K [Q1] → $156K (-$185K) [Q2]

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Research analyst outlook

We haven’t received any recent analyst ratings for XCUR.

Financial journalist opinion

Charts implemented using Lightweight Charts™